We report a case of transient anti-HBs (antibodies to hepatitis B surface antigen) and anti-HBc (antibodies to hepatitis B core antigen) seropositivity following IVIg administration for GBS, despite negative pre-treatment serology and absence of hepatitis B infection. The gene discussed is KRT88P; the disease is Guillain-Barre syndrome.